The short answer
Ginger powder may change average glucose control, but added hypoglycemia with insulin glargine has not been established.
What this answer covers
Dried Zingiber officinale rhizome powder, sold as root powder; oils and concentrated extracts differ. Exact insulin glargine scope.
- Supplement or preparation
- Zingiber Officinale (Ginger) Root Powder
- Medication ingredient
- insulin glargine
The powder study measured glucose control
An eight-week powder trial reported lower fasting glucose and HbA1c. Its abstract does not establish an exact insulin glargine treatment subgroup.
The endpoint limits the conclusion
Improved average glucose is not proof of a clinical low-glucose event from this combination. It also does not demonstrate insulin-related ginger depletion or a supplement requirement.
No tested spacing solution was provided
The study did not establish a protective interval between powder and insulin. Its preparation-specific findings do not cover every ginger extract or blend.
Keep the insulin plan product-specific
Discuss the exact product and amount with the diabetes team and follow your glucose-monitoring and low-glucose treatment plan. Do not adjust insulin yourself. Lantus and Toujeo have different concentrations and switching instructions. Keep the prescribed product and schedule; do not switch doses on your own.
Evidence and practical considerations
Side effects & toxicity
Powder efficacy evidence establishes neither exact insulin glargine hypoglycemia nor a supplement requirement or protective interval.
- Exact scope
- Dried Zingiber officinale rhizome powder, sold as root powder; oils and concentrated extracts differ. Exact insulin glargine scope. with insulin glargine RxCUI274783 IN; single-insulin subcutaneous product, concentration and schedule specific.
- Medication form and route
- subcutaneous insulin glargine; oral supplement
What remains uncertain
- No exact event rate or arbitrary insulin change.
Factors that may matter: Product; Dose; Meals; Other diabetes treatment; Kidney and liver function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed LANTUS U-100
Hypoglycemia can be severe; meal, activity and glucose-active treatment changes can require increased monitoring and clinician review. No intravenous or pump use. Once daily at the same time each day. Product-specific switching instructions distinguish concentrations.
How this applies: Exact insulin glargine RxCUI274783 IN, single-insulin product scope. Combination products not assumed equivalent.
No exact supplement interaction rate. Long-acting insulin is not a rapid mealtime formulation; concentration and device matter.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed TOUJEO U-300
Hypoglycemia can be severe; meal, activity and glucose-active treatment changes can require increased monitoring and clinician review. No intravenous or pump use. Once daily at the same time each day. Product-specific switching instructions distinguish concentrations.
How this applies: Exact insulin glargine RxCUI274783 IN, single-insulin product scope. Combination products not assumed equivalent.
No exact supplement interaction rate. Long-acting insulin is not a rapid mealtime formulation; concentration and device matter.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 88participants with type 2 diabetes.
Ginger powder reduced fasting glucose and HbA1c measures relative to the study comparison; hypoglycemia rates not supplied.
How this applies: Indirect for exact insulin glargine; original study drug, preparation and endpoint retained.
Powder efficacy trial does not establish exact insulin glargine co-use, clinical hypoglycemia incidence, supplement need or spacing.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact basal-insulin article with independently inspected product labels and original endpoint limits. | |
| Research summary published |
Article revision: 77ad4438f3bead3f
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.